Literature DB >> 9587953

Blood-brain barrier equilibration of codeine in rats studied with microdialysis.

R Xie1, M Hammarlund-Udenaes.   

Abstract

PURPOSE: The purpose of the study was to investigate the distribution of codeine across the blood-brain barrier (BBB) in rats by microdialysis (MD).
METHODS: Rats were administered intravenous infusion of codeine in doses of (1) 10 mg/kg, (2) 20 mg/kg for 10 min, and (3) an exponential infusion for 2 h aiming at a plasma concentration of 2500 ng/ml, in a crossover design (n = 6). Microdialysis was used to determine codeine unbound concentrations in blood and brain extracellular fluid (ECF). Total brain tissue and plasma concentrations were also determined. Nalorphine was used as a calibrator for measurement of in vivo recovery.
RESULTS: Relative recovery and retrodialysis loss of codeine and nalorphine were similar both in vitro and in vivo. Codeine was rapidly transported into the brain ECF with identical influx and efflux clearance across the BBB. The AUC ratios of brain to blood were 0.99 +/- 0.25 and 0.95 +/- 0.16 for Dose 1 and 2, respectively. The Css ratio of brain to blood was 1.06 +/- 0.12 for the exponential infusion. The half-lives were 25 +/- 4 min, 22 +/- 2 min in blood and 27 +/- 5 min, 25 +/- 5 min in brain for Dose 1 and Dose 2, respectively. Total brain tissue concentrations were 3.6 +/- 1.2-fold higher than the unbound concentrations in brain. Codeine was demethylated to morphine with an unbound AUCblood,morphine/AUCblood,codeine ratio of 7.7 +/- 5.1% in blood. No morphine was detected in brain MD, but total concentrations were possible to measure.
CONCLUSIONS: Codeine rapidly reached a distributional equilibrium with equal unbound concentrations in blood and brain. The brain transport of codeine did not show any dose-dependency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9587953     DOI: 10.1023/a:1011929910782

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

Review 1.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

2.  The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using a microdialysis-pharmacokinetic approach.

Authors:  Y Wang; D F Welty
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

3.  Determination of brain interstitial concentrations by microdialysis.

Authors:  H Benveniste; A J Hansen; N S Ottosen
Journal:  J Neurochem       Date:  1989-06       Impact factor: 5.372

4.  Lipid solubility and drug penetration of the blood brain barrier.

Authors:  W H Oldendorf
Journal:  Proc Soc Exp Biol Med       Date:  1974-12

5.  Active uptake of dihydromorphine and other narcotic analgesics by cerebral cortical slices.

Authors:  J T Scrafani; C C Hug
Journal:  Biochem Pharmacol       Date:  1968-08       Impact factor: 5.858

6.  Fluconazole distribution to the brain: a crossover study in freely-moving rats using in vivo microdialysis.

Authors:  H Yang; Q Wang; W F Elmquist
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

7.  Pharmacokinetics of fentanyl administered by computer-controlled infusion pump.

Authors:  S L Shafer; J R Varvel; N Aziz; J C Scott
Journal:  Anesthesiology       Date:  1990-12       Impact factor: 7.892

8.  Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.

Authors:  Z R Chen; A A Somogyi; G Reynolds; F Bochner
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

9.  Analysis of brain uptake and loss or radiotracers after intracarotid injection.

Authors:  M W Bradbury; C S Patlak; W H Oldendorf
Journal:  Am J Physiol       Date:  1975-10

Review 10.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part I).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

View more
  21 in total

1.  Role of the dorsomedial medulla in suppression of cough by codeine in cats.

Authors:  Ivan Poliacek; Michal Simera; Marcel Veternik; Zuzana Kotmanova; Donald C Bolser; Peter Machac; Jan Jakus
Journal:  Respir Physiol Neurobiol       Date:  2017-08-01       Impact factor: 1.931

Review 2.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

3.  An integrated model for the analysis of pharmacokinetic data from microdialysis experiments.

Authors:  Karin Tunblad; Margareta Hammarlund-Udenaes; E Niclas Jonsson
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

4.  Methodological aspects of the use of a calibrator in in vivo microdialysis-further development of the retrodialysis method.

Authors:  M R Bouw; M Hammarlund-Udenaes
Journal:  Pharm Res       Date:  1998-11       Impact factor: 4.200

Review 5.  Transporter-Mediated Disposition of Opioids: Implications for Clinical Drug Interactions.

Authors:  Robert Gharavi; William Hedrich; Hongbing Wang; Hazem E Hassan
Journal:  Pharm Res       Date:  2015-05-14       Impact factor: 4.200

6.  Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain.

Authors:  Jeffrey J Lochhead; Gwen McCaffrey; Lucy Sanchez-Covarrubias; Jessica D Finch; Kristin M Demarco; Colleen E Quigley; Thomas P Davis; Patrick T Ronaldson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-11       Impact factor: 4.733

Review 7.  Differences between opioids: pharmacological, experimental, clinical and economical perspectives.

Authors:  Asbjørn M Drewes; Rasmus D Jensen; Lecia M Nielsen; Joanne Droney; Lona L Christrup; Lars Arendt-Nielsen; Julia Riley; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2013-01       Impact factor: 4.335

Review 8.  Central mechanisms II: pharmacology of brainstem pathways.

Authors:  D C Bolser
Journal:  Handb Exp Pharmacol       Date:  2009

Review 9.  Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.

Authors:  Mellar Davis
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 10.  Current and future centrally acting antitussives.

Authors:  Donald C Bolser
Journal:  Respir Physiol Neurobiol       Date:  2006-03-06       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.